CVE-2012-0313
Cross-site scripting (XSS) vulnerability in glucose 2 before stage 6.2 allows remote attackers to...
Cross-site scripting (XSS) vulnerability in glucose 2 before stage 6.2 allows remote attackers to inject arbitrary web script or HTML via an RSS feed.
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting (XSS) vulnerability in glucose 2 before stage 6.2 allows remote attackers to inject arbitrary web script or HTML via an RSS feed.
- Record
CVE-2012-0313- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in glucose 2 before stage 6.2 allows remote attackers to inject arbitrary web script or HTML via an RSS feed.
- Record
CVE-2012-0313- Updated
- 2026-11-02
EUVDEUVD-2012-0349 No score
Cross-site scripting (XSS) vulnerability in glucose 2 before stage 6.2 allows remote attackers to inject arbitrary web script or HTML via an RSS feed.
- Record
EUVD-2012-0349- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-pcmx-prh4-3w5r No score
Cross-site scripting (XSS) vulnerability in glucose 2 before stage 6.2 allows remote attackers to...
Cross-site scripting (XSS) vulnerability in glucose 2 before stage 6.2 allows remote attackers to inject arbitrary web script or HTML via an RSS feed.
- Record
GHSA-pcmx-prh4-3w5r- Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2012-0313 is a medium vulnerability (CVSS 4.3) in Glucose 2, published January 24, 2012. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.04%, the 64th percentile. No source names a fixed version.